Ketanserin alters [3H]serotonin uptake and release in rat hypothalamus.
Ketanserin, a serotonin2 receptor antagonist, evoked a dose-related non-calcium dependent release of tritium from slices of rat hypothalamus preloaded with [3H]serotonin. Concentrations of 1, 5 and 10 microM ketanserin caused a 0.5%, 64% and 110% increase, respectively, in tritium release. Chlorimipramine, a potent inhibitor of the serotonin uptake mechanism, did not alter the spontaneous release of tritium. In addition, 5 microM ketanserin reduced high affinity uptake of 0.1 microM [3H]serotonin into rat hypothalamus slices by 36%. These data suggest ketanserin possesses 'amphetamine-like' releasing activity and an uptake inhibitory action on serotonin nerve terminals. Both of these properties could mask 5-HT receptor antagonism in vitro and in vivo.
D000818:Animals; D002118:Calcium / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D007031:Hypothalamus / Q000378:metabolism*; D066298:In Vitro Techniques; D007650:Ketanserin; D008297:Male; D010880:Piperidines / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D012701:Serotonin / Q000378:metabolism*; D012702:Serotonin Antagonists / Q000494:pharmacology*; D014316:Tritium
D010880:Piperidines; D012702:Serotonin Antagonists; D014316:Tritium; D012701:Serotonin; D007650:Ketanserin; D002118:Calcium